as on September 6, 2025 at 1:29 am IST
Day's Low
Day's High
1.04%
Downside
0.61%
Upside
52 Week's Low
52 Week's High
26.26%
Downside
14.34%
Upside
Check Jazz Pharmaceuticals Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.8B
EPS (TTM)
5.2954
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.19%
PE Ratio (TTM)
18.08
Industry PE ratio
9.62
P/B Ratio
0PEG Ratio
5.8045
EBITDA
1.6B
Revenue (TTM)
4.1B
Profit Margin
-9.91%
Return On Equity TTM
77254600.00%
Track how Jazz Pharmaceuticals Plc P/E has moved over time to understand its valuation trends.
Jazz Pharmaceuticals Plc in the last 5 years
Lowest (5.56x)
December 31, 2024
Industry (9.62x)
September 5, 2025
Today (18.08x)
September 5, 2025
Highest (31.58x)
June 30, 2025
Today’s Price to Earnings Ratio: 18.08x
Compare market cap, revenue, PE, and other key metrics of Jazz Pharmaceuticals Plc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $7.8B | -2.79% | 18.08 | -9.91% | |
BUY | $59.4B | 269.24% | -505.15 | -12.96% | |
NA | $39.4B | NA | NA | -3.89% | |
BUY | $101.8B | 48.94% | 28.25 | 31.86% | |
BUY | $59.8B | -2.26% | 14.21 | 31.37% |
The Jazz Pharmaceuticals Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Jazz Pharmaceuticals Plc investment value today
Current value as on today
₹1,24,520
Returns
₹24,520
(+24.52%)
Returns from Jazz Pharmaceuticals Plc Stock
₹19,467 (+19.47%)
Dollar Returns*
₹5,054 (+5.05%)
Based on 25 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 25 analysts, 80% of analysts recommend a 'BUY' rating for Jazz Pharmaceuticals Plc. Average target price of $186.47
Get share price movements and forecasts by analysts on Jazz Pharmaceuticals Plc.
What analysts predicted
30.56%UPSIDE
Target Price
$186.47
Current Price
$129.49
Analyzed by
25 Analysts
Target
$186.47
Jazz Pharmaceuticals Plc target price $186.47, a slight upside of 30.56% compared to current price of $129.49. According to 25 analysts rating.
Search interest for Jazz Pharmaceuticals Plc Stock has increased by 69% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:69% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, JAZZ stock has moved up by 13.0%
Revenue Rich
Revenue is up for the last 2 quarters, 897.84M → 1.04B (in $), with an average increase of 14.1% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.4% return, outperforming this stock by 62.3%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.8% return, outperforming this stock by 138.2%
Profit Down
Netprofit is down for the last 4 quarters, 215.05M → -718.47M (in $), with an average decrease of 278.6% per quarter
Organisation | Jazz Pharmaceuticals Plc |
Headquarters | Waterloo Exchange, Dublin, Ireland, D04 E5W7 |
Industry | Health Technology |
CEO | Ms. Renee D. Gala |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Renee D. Gala | President, COO, CEO & Director |
Mr. Philip L. Johnson | Executive VP & CFO |
Ms. Patricia Carr | Senior VP & Chief Accounting Officer |
Mr. Jeff Macdonald | Executive Director of Investor Relations |
Ms. Heidi Manna | Executive VP & Chief People Officer |
Dr. Jed Black M.D. | Senior Vice President of Sleep & CNS Medicine |
Mr. Bruce C. Cozadd | Co-Founder & Chairman |
Ms. Samantha Pearce | Executive VP & Chief Commercial Officer |
Ms. Neena M. Patil J.D. | Executive VP & Chief Legal Officer |
Dr. Robert Iannone M.D. | Executive VP, Chief Medical Officer and Global Head of Research & Development |
Jazz Pharmaceuticals Plc share price today is $129.49 as on at the close of the market. Jazz Pharmaceuticals Plc share today touched a day high of $130.28 and a low of $128.14.
Jazz Pharmaceuticals Plc share touched a 52 week high of $148.06 on and a 52 week low of $95.49 on . Jazz Pharmaceuticals Plc stock price today i.e. is closed at $129.49,which is 12.54% down from its 52 week high and 35.61% up from its 52 week low.
Jazz Pharmaceuticals Plc market capitalisation is $0.01T as on .
Indian investors can start investing in Jazz Pharmaceuticals Plc (JAZZ) shares with as little as ₹88.233 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.33 in Jazz Pharmaceuticals Plc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Jazz Pharmaceuticals Plc share’s latest price of $129.49 as on September 6, 2025 at 1:29 am IST, you will get 0.0772 shares of Jazz Pharmaceuticals Plc. Learn more about
fractional shares .
Jazz Pharmaceuticals Plc stock has given -2.79% share price returns and 19.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?